| Literature DB >> 35402414 |
Arathi Sreenikethanam1, Subhisha Raj1, Rajesh Banu J2, Poornachandar Gugulothu2, Amit K Bajhaiya1.
Abstract
Microalgae are highly diverse photosynthetic organisms with higher growth rate and simple nutritional requirements. They are evolved with an efficiency to adapt to a wide range of environmental conditions, resulting in a variety of genetic diversity. Algae accounts for nearly half of global photosynthesis, which makes them a crucial player for CO2 sequestration. In addition, they have metabolic capacities to produce novel secondary metabolites of pharmaceutical, nutraceutical and industrial applications. Studies have explored the inherent metabolic capacities of microalgae with altered growth conditions for the production of primary and secondary metabolites. However, the production of the targeted metabolites at higher rates is not guaranteed just with the inherent genetic potentials. The strain improvement using genetic engineering is possible hope to overcome the conventional methods of culture condition improvements for metabolite synthesis. Although the advanced gene editing tools are available, the gene manipulation of microalgae remains relatively unexplored. Among the performed gene manipulations studies, most of them focus on primary metabolites with limited focus on secondary metabolite production. The targeted genes can be overexpressed to enhance the production of the desired metabolite or redesigning them using the synthetic biology. A mutant (KOR1) rich in carotenoid and lipid content was developed in a recent study employing mutational breeding in microalgae (Kato, Commun. Biol, 2021, 4, 450). There are lot of challenges in genetic engineering associated with large algal diversity but the numerous applications of secondary metabolites make this field of research very vital for the biotech industries. This review, summarise all the genetic engineering studies and their significance with respect to secondary metabolite production from microalgae. Further, current genetic engineering strategies, their limitations and future strategies are also discussed.Entities:
Keywords: genetic engineering; high value products; microalgae; secondary metabolites; synthetic biology; transformation
Year: 2022 PMID: 35402414 PMCID: PMC8984019 DOI: 10.3389/fbioe.2022.836056
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Microalgal secondary metabolites and its applications.
| Class | Secondary metabolite | Organism | Percentage (dry weight) | Applications | References |
|---|---|---|---|---|---|
| Carotenoids | β-carotene |
| 0.2–1% | Anti-inflammatory, Anti-oxidant, food colorant, Vitamin A precursor, Reduces macular degeneration and colorectal cancer risk | ( |
| — | — | — | — | ||
| Lutein |
| 0.5–1.2% | Prevents age-related cataract and maculopathy, anti-tumor, food coloring agent (egg-yolk coloring agent), feed additive, anti-oxidant | ( | |
| — | — | — | — | ||
| Astaxanthin |
| 1–8% | Anti-inflammatory, Anti-oxidant, anti-tumour, food coloring agent, poultry and aquaculture feed additive, anti-ageing, sun protection, anti-diabetic | ||
| — | — | — | — | ||
| — | — | — | — |
| |
| Violaxanthin |
| — | Anti-inflammatory, Anti-tumor | ( | |
| — | — | — | — | ||
| Zeaxanthin |
| 1–2% | Anti-inflammatory, Anti-oxidant, prevents age related cataract, reduces macular degeneration | ||
| — | — | — | — | ||
| — | — | — | — |
| |
| Fucoxanthin | Phaeodactylum tricornutum, Isochrysis sp | >1.5% | Anti-inflammatory, Anti-oxidant, anti-cancer, anti-obesity, prevents cerebrovascular diseases | ( | |
| Polyunsaturated Fatty Acids (PUFAs) | — |
| — | Role in neurogenesis and neurotransmission, treatment of various diseases (cancer, atherosclerosis, rheumatoid arthritis, Alzheimer’s, and psoriasis), anti-inflammatory, nutrition supplements | ( |
| — | — | — | — | ||
| — | — | — | — | ||
| Tocopherols | — | Porphydium sp., Spirulina platensis, Desmodesmus sp. | — | Vitamin-E antioxidant activity, anti-inflammatory, anti-tumoural | |
| — | — | ||||
| phenolic compounds | hydroxycinnamic acids |
| — | Anti-oxidant, anti-inflammatory | |
| 4-hydroxybenzaldehyde | Spongiochloris spongiosa, Spirulina platensis, Anabaena doliolum, Nostoc | — | — | ||
| 3,4-dihydroxybenzaldehyde | Spongiochloris spongiosa, Spirulina platensis, Anabaena doliolum, Nostoc sp., Cylindrospermum sp. | — | — | — | |
| Vanillic/syringic/caffeic/chlorogenic acid | Spirulina sp. | — | — | — | |
| Phycobiliproteins | phycocyanin |
| About 20% | food and cosmetics coloring agent, fluorescence immunoassays reagent, anti-oxidant | |
| phycoerythrin |
| — | fluorescence immunoassays reagent, label for biological molecules | — | |
| Mycosporine like Amino acids |
| — | Sunscreen, anti-inflammatory, anti-tumour, anti-oxidative, wound healing | (Llewellyn, n.d | |
| — |
| ||||
| — | |||||
| scytonemin | — |
| — | Anti-inflammatory, Anti-proliferation, sun protection | (Llewellyn, n.d.) |
| — | — | — | — |
FIGURE 1Advantages and Disadvantages of transformation methods used in algal genetic engineering. Transformation of a cell refers to integration of a desired gene at the target site. Although, genetic engineering is a highly efficient and sophisticated technique, there are certain disadvantages along with its advantages.
FIGURE 2Steps involved in secondary metabolite production using genetic engineering. Primarily, the cells are screened on the basis of growth rate and higher productivity. Further, transcriptome analysis is performed to select the target, followed by designing editing tools and transformation of the gene of interest into the target site. The transformants with the desired traits selected can either be used to perform omic analysis and profile analysis to identify any novel metabolites or directly can be used for mass cultivation and expression studies. If any novel metabolites identified, the product is commercialized.